Benelyte
Every registration of this product has been cancelled.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Fresenius Kabi South Africa (Pty) LtdCancelled | Benelyte | Not stated | 500875 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Benelyte Each 1 ml solution contains GLUCOSE MONOHYDRATE EQUIVALENT TO GLUCOSE 10,0 mg and SODIUM CHLORIDE 6,429 mg and POTASSIUM CHLORIDE 0,298 mg and CALCIUM CHLORIDE DIHYDRATE 0,147 mg and MAGNESIUM CHLORIDE HEXAHYDRATE 0,203 mg and SODIUM ACETATE TRIHYDRATE 4,082 mg | Not listed | 50087550/24/0875 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.